Kenya - English - Pharmacy and Poisons Board

lincoln pharmaceuticals ltd c/o medox… p.o box 52771 - 00200 - quinine sulphate - coated tablet - quinine sulphate 300 mg - quinine

Kenya - English - Pharmacy and Poisons Board

universal corporation limited club road plot no:13777 p.o.box 1748-00902 kikuyu - quinine sulphate - tablet - each tablet contains quinine sulphate 300mg - antimalarial antiprotozoals: methanolquinolines

Malta - English - Medicines Authority

wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - quinine sulfate - coated tablet - quinine sulfate 300 mg - antiprotozoals

Ireland - English - HPRA (Health Products Regulatory Authority)

teva b.v. - quinine sulfate - film-coated tablet - 300 milligram(s) - methanolquinolines; quinine

Kenya - English - Pharmacy and Poisons Board

macleods pharmaceuticals limited atlanta arcade church road near leela hotel - quinine sulphate tablets bp 300 mg - film-coated tablet - each film coated tablet contains: quinine… - antimalarial antiprotozoals: methanolquinolines

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis uk limited - quinine sulfate - coated tablets - 300 milligram - methanolquinolines

Namibia - English - Namibia Medicines Regulatory Council

pharmacare limited - quinine sulphate - tablet - quinine sulphate tablets 300mg

United States - English - NLM (National Library of Medicine)

american health packaging - quinine sulfate (unii: kf7z0e0q2b) (quinine - unii:a7v27phc7a) - quinine sulfate 324 mg - quinine sulfate capsules are an antimalarial drug indicated only for treatment of uncomplicated plasmodium falciparum malaria. quinine sulfate has been shown to be effective in geographical regions where resistance to chloroquine has been documented [see clinical studies (14)]. limitations of use: quinine sulfate oral capsules are not approved for: - treatment of severe or complicated p. falciparum malaria. - prevention of malaria. - treatment or prevention of nocturnal leg cramps [see warnings and precautions (5.1)]. quinine sulfate capsules are contraindicated in patients with the following: - prolonged qt interval. one case of a fatal ventricular arrhythmia was reported in an elderly patient with a prolonged qt interval at baseline, who received quinine sulfate intravenously for p. falciparum malaria [see warnings and precautions (5.4)]. - known hypersensitivity reactions to quinine. these include, but are not limited to, the following [see warnings and p

United States - English - NLM (National Library of Medicine)

lupin pharmaceuticals, inc. - quinine sulfate (unii: kf7z0e0q2b) (quinine - unii:a7v27phc7a) - quinine sulfate 324 mg - quinine sulfate capsule usp is an antimalarial drug indicated only for treatment of uncomplicated plasmodium falciparum malaria. quinine sulfate has been shown to be effective in geographical regions where resistance to chloroquine has been documented [see clinical studies (14)] . quinine sulfate capsules usp are not approved for: - treatment of severe or complicated p. falciparum malaria. - prevention of malaria. - treatment or prevention of nocturnal leg cramps [see warnings and precautions (5.1)] . quinine sulfate is contraindicated in patients with the following:   •  prolonged qt interval. one case of a fatal ventricular arrhythmia was reported in an elderly patient with a prolonged qt interval at baseline, who received quinine sulfate intravenously for p. falciparum malaria [see warnings and precautions (5.3)].   •  glucose-6-phosphate dehydrogenase (g6pd) deficiency.   •  hemolysis can occur in patients with g6pd deficiency receiving quinine.   •  known hypersensitivity reactions to quin

United States - English - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - quinine sulfate (unii: kf7z0e0q2b) (quinine - unii:a7v27phc7a) - quinine sulfate 324 mg - quinine sulfate capsules are an antimalarial drug indicated only for treatment of uncomplicated plasmodium falciparum malaria. quinine sulfate has been shown to be effective in geographical regions where resistance to chloroquine has been documented [see clinical studies (14) ]. limitations of use: quinine sulfate oral capsules are not approved for: quinine sulfate capsules are contraindicated in patients with the following: risk summary prolonged experience with quinine in pregnant women over several decades, based on published prospective and retrospective observational studies, surveys, safety and efficacy studies, review articles, case reports and case series have not identified a drug associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes (see data) . in animal reproduction studies, administration of quinine by multiple routes of administration to pregnant rabbits, dogs, guinea pigs, rats, and monkeys during the period of organogenesis at doses of 0.25 to 2 times the m